Healthcare cost may go up post GST: Apollo Hospitals Ruby Khatun Khatun22 Jun 2017 11:20 AM ISTNew Delhi: Overall healthcare cost could increase post GST as some services and products will be taxed at 15-18 per cent, although healthcare per se...
Amar Remedies files for bankruptcy petition Ruby Khatun Khatun22 Jun 2017 10:32 AM ISTMumbai: Amar Remedies, a Mumbai-based company, which is manufacturing personal healthcare products is heading for liquidation as the company has filed...
Government of India bans Gemifloxacin, Ambroxol combination Ruby Khatun Khatun22 Jun 2017 10:20 AM ISTDepartment of Health and Family Welfare of Ministry of Health and Family Welfare, Government of India has banned fixed dose combinations Gemifloxacin...
Glenmark, APC Therapeutics ink licensing pact for cancer drug Ruby Khatun Khatun22 Jun 2017 9:52 AM ISTNew Delhi: Domestic pharma major Glenmark Pharmaceuticals has entered into a licensing agreement with Boston-based APC Therapeutics Inc for...
NPPA to set ceiling prices exclusive of GST rates Ruby Khatun Khatun22 Jun 2017 9:22 AM ISTNPPA in its 46th meeting held on 0.3 6.2017 has decided to notify ceiling prices of Scheduled formulations exclusive of applicable GST rates, after...
Alembic Pharma gets USFDA nod for generic hypertension drug Ruby Khatun Khatun22 Jun 2017 9:15 AM ISTNew Delhi: Alembic Pharmaceuticals has received US health regulator's approval to market hypertension drug, candesartan cilexetil tablets, in the...
Zydus Cadila receives EIR for Moraiya manufacturing facility Ruby Khatun Khatun22 Jun 2017 9:02 AM ISTMumbai: Pharma Major, Zydus Cadila's formulations manufacturing facility at Moraiya, Ahmedabad has received an Establishment Inspection Report (EIR)...
Zydus Cadila gets USFDA nod to market anti-inflammatory drug Ruby Khatun Khatun21 Jun 2017 3:04 PM ISTNew Delhi: Zydus Cadila has received approval from the US health regulator to market anti- inflammatory Diflunisal tablets in America."The company has...
Eris Lifesciences IPO oversubscribed 3.29 times on last day Ruby Khatun Khatun21 Jun 2017 3:04 PM ISTNew Delhi: The initial public offer of Eris Lifesciences was oversubscribed 3.29 times on the last day of the three-day bidding.The IPO, looking to...
FDA approves new antibiotic, Baxdela to treat serious skin infections Ruby Khatun Khatun21 Jun 2017 12:39 PM ISTThe U.S. Food and Drug Administration on Monday approved a new treatment for patients with acute bacterial skin infections, made by privately held...
Narendra Modi pays maiden visit to CDRI, 3 new drugs to be introduced Ruby Khatun Khatun21 Jun 2017 11:19 AM ISTLucknow:Prime Minister Narendra Modi recently visited the premier CSIR-Central Drugs Research Institute (CDRI) here and evinced keen interest in the...
AstraZeneca gets DCGI node for marketing asthma drug in India Ruby Khatun Khatun21 Jun 2017 11:08 AM IST Mumbai: AstraZeneca has received the approval for marketing its asthma drug Symbicort Turbuhaler in India from Drug Controller General of India...
